Abstract Details
Mehdi Bouslama, MD
(University at Buffalo Neurosurgery)
PRESENTER |
Dr. Bouslama has nothing to disclose. |
Diogo C. Haussen, MD | Dr. Haussen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stryker. Dr. Haussen has received stock or an ownership interest from Viz AI. |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Michael R. Frankel, MD (Emory Univ School of Med/Dept of Neuro) | The institution of Dr. Frankel has received research support from Nico Corporation, Inc. |
Raul G. Nogueira, MD (UPMC Stroke Institute) | Dr. Nogueira has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for for advisory roles with Anaconda, Biogen, Cerenovus, Genentech, Hybernia, Imperative Care, Medtronic, Phenox, Philips, Prolong Pharmaceuticals, Stryker Neurovascular, Shanghai Wallaby, and Synchron (consulting fees) as well as for advisory roles with Astrocyte, Brainomix, Cerebrotech, Ceretrieve, Corindus Vascular Robotics, Vesalio, Viz-AI, RapidPulse and Perfuze ( stock options). Dr. Nogueira has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Law Firms. Dr. Nogueira has received stock or an ownership interest from Viz-AI, Perfuze, Cerebrotech, Reist/Q'Apel Medical, Truvic, and Viseon. The institution of Dr. Nogueira has received research support from Cerenovus. |